During the past decade, San Antonio Endovascular and Heart Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Antonio Endovascular and Heart Institute" #1 sponsor was "Amgen" with 1 trials, followed by "Brigham and Women's Hospital" with 1 trials sponsored, "Cardiovascular Systems Inc" with 1 trials sponsored, "Cardiva Medical, Inc." with 1 trials sponsored and "CeloNova BioSciences, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Antonio Endovascular and Heart Institute" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "San Antonio Endovascular and Heart Institute" are "Coronary Artery Disease" (3 trials), "ASCVD" (1 trials), "Angina Pectoris" (1 trials), "Cardiovascular Disease" (1 trials) and "Insulin Resistance" (1 trials). Many other conditions were trialed in "San Antonio Endovascular and Heart Institute" in a lesser frequency.

Most popular intervention types in "San Antonio Endovascular and Heart Institute" are "Drug" (3 trials), "Device" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ACE-I (lisinopril) or ARB (losartan)" (1 trials), "Aspirin" (1 trials), "COBRA PzF" (1 trials) and "Cardiva Medical VASCADE VCS" (1 trials). Other intervention names were less common.

The vast majority of trials in "San Antonio Endovascular and Heart Institute" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "San Antonio Endovascular and Heart Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in San Antonio Endovascular and Heart Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in San Antonio Endovascular and Heart Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".